Issue 3 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

24

No.

3

January 23, 1998Jan 23, 1998

Free

DOWNLOAD THE PDF

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

Research Funding: 30 Groups Sign Letter For Double NCI Budget

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

Recent Issues

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026